Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mukta Arora

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphomaNoel Laudi, Mukta Arora, Linda J Burns, et al.
American Journal of Hematology|July 10, 2007
Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysisCatherine M Flynn, Betsy Hirsch, Todd Defor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2018
Late Mortality after Allogeneic Bone Marrow Transplantation in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic AnemiaAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Blood|May 13, 2017
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host diseasePaul J Martin, Barry E Storer, Yoshihiro Inamoto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2020
Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplantation RecipientsDivya Bhargava, Mukta Arora, Todd E DeFor, et al.
Cancer|May 16, 2020
Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor StudyMukta Arora, Yanjun Chen, Lindsey Hageman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2019
Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor StudyRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Transplantation and Cellular Therapy|April 8, 2021
Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for LymphomaNajla El Jurdi, Christina Fair, John Rogosheske, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2018
Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)Aman Wadhwa, Yanjun Chen, Anna Holmqvist, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphomaNavneet S Majhail, Daniel J Weisdorf, Todd E Defor, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 1, 2005
Long-term follow-up after autologous hematopoietic stem cell transplantation for low-grade non-Hodgkin lymphomaNoel Laudi, Mukta Arora, Linda J Burns, et al.
American Journal of Hematology|July 10, 2007
Reduced intensity compared with high dose conditioning for allotransplantation in acute myeloid leukemia and myelodysplastic syndrome: a comparative clinical analysisCatherine M Flynn, Betsy Hirsch, Todd Defor, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 23, 2018
Late Mortality after Allogeneic Bone Marrow Transplantation in Childhood for Bone Marrow Failure Syndromes and Severe Aplastic AnemiaAnna Sällfors Holmqvist, Yanjun Chen, Jessica Wu, et al.
Blood|May 13, 2017
An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host diseasePaul J Martin, Barry E Storer, Yoshihiro Inamoto, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 12, 2020
Use of Potentially Inappropriate Medications in Older Allogeneic Hematopoietic Cell Transplantation RecipientsDivya Bhargava, Mukta Arora, Todd E DeFor, et al.
Cancer|May 16, 2020
Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor StudyMukta Arora, Yanjun Chen, Lindsey Hageman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 7, 2019
Venous Thromboembolism in Autologous Blood or Marrow Transplantation Survivors: A Report from the Blood or Marrow Transplant Survivor StudyRadhika Gangaraju, Yanjun Chen, Lindsey Hageman, et al.
Transplantation and Cellular Therapy|April 8, 2021
Effect of Keratinocyte Growth Factor on Hospital Readmission and Regimen-Related Toxicities after Autologous Hematopoietic Cell Transplantation for LymphomaNajla El Jurdi, Christina Fair, John Rogosheske, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 8, 2018
Late Mortality after Allogeneic Blood or Marrow Transplantation for Inborn Errors of Metabolism: A Report from the Blood or Marrow Transplant Survivor Study-2 (BMTSS-2)Aman Wadhwa, Yanjun Chen, Anna Holmqvist, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphomaNavneet S Majhail, Daniel J Weisdorf, Todd E Defor, et al.
Pageof 17